Cargando…
A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compen...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225223/ https://www.ncbi.nlm.nih.gov/pubmed/27488112 http://dx.doi.org/10.1007/s11011-016-9881-3 |
_version_ | 1782493477521588224 |
---|---|
author | Grover, Vijay P. B. McPhail, Mark J. W. Wylezinska-Arridge, Marzena Crossey, Mary M. E. Fitzpatrick, Julie A. Southern, Louise Saxby, Brian K. Cook, Nicola A. Cox, I. Jane Waldman, Adam D. Dhanjal, Novraj S. Bak-Bol, Aluel Williams, Roger Morgan, Marsha Y. Taylor-Robinson, Simon D. |
author_facet | Grover, Vijay P. B. McPhail, Mark J. W. Wylezinska-Arridge, Marzena Crossey, Mary M. E. Fitzpatrick, Julie A. Southern, Louise Saxby, Brian K. Cook, Nicola A. Cox, I. Jane Waldman, Adam D. Dhanjal, Novraj S. Bak-Bol, Aluel Williams, Roger Morgan, Marsha Y. Taylor-Robinson, Simon D. |
author_sort | Grover, Vijay P. B. |
collection | PubMed |
description | The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compensated cirrhosis, seven of whom had minimal HE, were examined with cerebral 3 Tesla MR techniques, including T(1)- and T(2)-weighted, magnetization transfer and diffusion-weighted imaging and proton magnetic resonance spectroscopy sequences. Studies were repeated after a 4-week course of oral L-ornithine L-aspartate (LOLA). Results were compared with data obtained from 22 aged-matched healthy controls. There was no difference in mean total brain volume between patients and controls at baseline. Mean cerebral magnetization transfer ratios were significantly reduced in the globus pallidus and thalamus in the patients with cirrhosis irrespective of neuropsychiatric status; the mean ratio was significantly reduced in the frontal white matter in patients with minimal HE compared with healthy controls but not when compared with their unimpaired counterparts. There were no significant differences in either the median apparent diffusion coefficients or the mean fractional anisotropy, calculated from the diffusion-weighted imaging, or in the mean basal ganglia metabolite ratios between patients and controls. Psychometric performance improved in 50 % of patients with minimal HE following LOLA, but no significant changes were observed in brain volumes, cerebral magnetization transfer ratios, the diffusion weighted imaging variables or the cerebral metabolite ratios. MR variables, as applied in this study, do not identify patients with minimal HE, nor do they reflect changes in psychometric performance following LOLA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11011-016-9881-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5225223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-52252232017-01-24 A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy Grover, Vijay P. B. McPhail, Mark J. W. Wylezinska-Arridge, Marzena Crossey, Mary M. E. Fitzpatrick, Julie A. Southern, Louise Saxby, Brian K. Cook, Nicola A. Cox, I. Jane Waldman, Adam D. Dhanjal, Novraj S. Bak-Bol, Aluel Williams, Roger Morgan, Marsha Y. Taylor-Robinson, Simon D. Metab Brain Dis Original Article The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compensated cirrhosis, seven of whom had minimal HE, were examined with cerebral 3 Tesla MR techniques, including T(1)- and T(2)-weighted, magnetization transfer and diffusion-weighted imaging and proton magnetic resonance spectroscopy sequences. Studies were repeated after a 4-week course of oral L-ornithine L-aspartate (LOLA). Results were compared with data obtained from 22 aged-matched healthy controls. There was no difference in mean total brain volume between patients and controls at baseline. Mean cerebral magnetization transfer ratios were significantly reduced in the globus pallidus and thalamus in the patients with cirrhosis irrespective of neuropsychiatric status; the mean ratio was significantly reduced in the frontal white matter in patients with minimal HE compared with healthy controls but not when compared with their unimpaired counterparts. There were no significant differences in either the median apparent diffusion coefficients or the mean fractional anisotropy, calculated from the diffusion-weighted imaging, or in the mean basal ganglia metabolite ratios between patients and controls. Psychometric performance improved in 50 % of patients with minimal HE following LOLA, but no significant changes were observed in brain volumes, cerebral magnetization transfer ratios, the diffusion weighted imaging variables or the cerebral metabolite ratios. MR variables, as applied in this study, do not identify patients with minimal HE, nor do they reflect changes in psychometric performance following LOLA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11011-016-9881-3) contains supplementary material, which is available to authorized users. Springer US 2016-08-03 2017 /pmc/articles/PMC5225223/ /pubmed/27488112 http://dx.doi.org/10.1007/s11011-016-9881-3 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Grover, Vijay P. B. McPhail, Mark J. W. Wylezinska-Arridge, Marzena Crossey, Mary M. E. Fitzpatrick, Julie A. Southern, Louise Saxby, Brian K. Cook, Nicola A. Cox, I. Jane Waldman, Adam D. Dhanjal, Novraj S. Bak-Bol, Aluel Williams, Roger Morgan, Marsha Y. Taylor-Robinson, Simon D. A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy |
title | A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy |
title_full | A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy |
title_fullStr | A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy |
title_full_unstemmed | A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy |
title_short | A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy |
title_sort | longitudinal study of patients with cirrhosis treated with l-ornithine l-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225223/ https://www.ncbi.nlm.nih.gov/pubmed/27488112 http://dx.doi.org/10.1007/s11011-016-9881-3 |
work_keys_str_mv | AT grovervijaypb alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT mcphailmarkjw alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT wylezinskaarridgemarzena alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT crosseymaryme alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT fitzpatrickjuliea alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT southernlouise alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT saxbybriank alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT cooknicolaa alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT coxijane alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT waldmanadamd alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT dhanjalnovrajs alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT bakbolaluel alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT williamsroger alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT morganmarshay alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT taylorrobinsonsimond alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT grovervijaypb longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT mcphailmarkjw longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT wylezinskaarridgemarzena longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT crosseymaryme longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT fitzpatrickjuliea longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT southernlouise longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT saxbybriank longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT cooknicolaa longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT coxijane longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT waldmanadamd longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT dhanjalnovrajs longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT bakbolaluel longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT williamsroger longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT morganmarshay longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy AT taylorrobinsonsimond longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy |